Arrow - Quinapril 10 New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - quinapril 10

teva pharma (new zealand) limited - quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril - film coated tablet - 10 mg - active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

Arrow - Quinapril 20 New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - quinapril 20

teva pharma (new zealand) limited - quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril;  ; quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril - film coated tablet - 20 mg - active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE tablet, film coated
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE- qinapril h United States - English - NLM (National Library of Medicine)

quinapril hydrochloride and hydrochlorothiazide tablet, film coated quinapril hydrochloride and hydrochlorothiazide- qinapril h

physicians total care, inc. - quinapril hydrochloride (unii: 33067b3n2m) (quinapril - unii:rj84y44811), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - quinapril hydrochloride 10 mg - quinapril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension. this fixed combination is not indicated for the initial therapy of hypertension (see dosage and administration ). in using quinapril hydrochloride and hydrochlorothiazide, consideration should be given to the fact that another angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that quinapril does not have a similar risk (see warnings: neutropenia/agranulocytosis ). angioedema in black patients: black patients receiving ace inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non-blacks. it should also be noted that in controlled clinical trials, ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. quinapril hydrochloride and hydrochlorothiazide tablets are contra